<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36514167</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-9957</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Infectious diseases of poverty</Title><ISOAbbreviation>Infect Dis Poverty</ISOAbbreviation></Journal><ArticleTitle>Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China.</ArticleTitle><Pagination><StartPage>124</StartPage><MedlinePgn>124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40249-022-01028-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vaccine-derived poliovirus (VDPV) is a potential threat to polio eradication because they can reintroduce into the general population and cause paralytic polio outbreaks, a phenomenon that has recently emerged as a prominent public health concern at the end of global polio eradication. This study aimed to describe the epidemiology and genetic characteristics of the first VDPV identified from a patient with acute flaccid paralysis (AFP), with four doses of inactivated polio vaccine immunization in Henan Province, China in 2017.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The patient was diagnosed with type 3 VDPV. Subsequently, a series of epidemiological approaches was implemented, including a retrospective search of AFP cases, rate of vaccination assessment, study of contacts, and supplementary immunization activities. Fecal samples were collected, viral isolation was performed, and the viral isolates were characterized using full-length genomic sequencing and bioinformatic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Phylogenetic analysis showed that the viral isolates from the patient were different from other reported genetic clusters of type 3 VDPV worldwide. They were identified as a Sabin 3/Sabin 1 recombinant VDPV with a crossover site in the P2 region. Nucleotide substitutions, including U&#x2009;&#x2192;&#x2009;C (472) and C&#x2009;&#x2192;&#x2009;U (2493), have been identified, both of which are frequently observed as reversion mutations in neurovirulent type 3 poliovirus. A unique aspect of this case is that the patient had been vaccinated with four doses of inactive polio vaccine, and the serum neutralizing antibody for Sabin types 1 and 3 were 1&#x2236;16 and 1&#x2236;512, respectively. Thus, the patient was speculated to have been infected with type 3 VDPV, and the virus continued to replicate and be excreted for at least 41 d.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The existence of this kind of virus in human population is a serious risk and poses a severe challenge in maintaining a polio-free status in China. To the best of our knowledge, this is the first report of VDPV identified in the Henan province of China. Our results highlight the importance of maintaining a high-level vaccination rate and highly sensitive AFP case surveillance system in intercepting VDPV transmission.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mingyu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jianhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yiran</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Changshuang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mingxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoxiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Zhanpei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yating</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shuangli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2692-5437</Identifier><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. yongzhang75@sina.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China. yongzhang75@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China. zhangyy1984@139.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>182102310226</GrantID><Agency>Henan Province Key R&amp;D and Promotion</Agency><Country/></Grant><Grant><GrantID>LHGJ20190711</GrantID><Agency>Henan Province Medical Science and Technology Joint construction Project</Agency><Country/></Grant><Grant><GrantID>2021YFC2302003</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>L192014</GrantID><Agency>Natural Science Foundation of Beijing</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis Poverty</MedlineTA><NlmUniqueID>101606645</NlmUniqueID><ISSNLinking>2049-9957</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Epidemiological Survey</Keyword><Keyword MajorTopicYN="N">Genetic characterization</Keyword><Keyword MajorTopicYN="N">Henan</Keyword><Keyword MajorTopicYN="N">Recombination</Keyword><Keyword MajorTopicYN="N">Type 3 vaccine-derived poliovirus</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36514167</ArticleId><ArticleId IdType="pmc">PMC9749236</ArticleId><ArticleId IdType="doi">10.1186/s40249-022-01028-1</ArticleId><ArticleId IdType="pii">10.1186/s40249-022-01028-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587&#x2013;635. doi: 10.1146/annurev.micro.58.030603.123625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.58.030603.123625</ArticleId><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang. China N Engl J Med. 2013;369:1981&#x2013;1990. doi: 10.1056/NEJMoa1303368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303368</ArticleId><ArticleId IdType="pubmed">24256377</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283&#x2013;S293. doi: 10.1093/infdis/jiu295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu295</ArticleId><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu S, Yan D, Wang D, Li X, Zhu H, et al. Type I vaccine-derived polioviruses in China from 1995 to 2019. Biosafety and Health. 2019;1:155&#x2013;158. doi: 10.1016/j.bsheal.2019.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2019.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L, Benschop KSM, Nguyen D, Kamau E, Pajkrt D, Simmonds P, et al. Recombination analysis of non-poliovirus members of the enterovirus c species; restriction of recombination events to members of the same 3DPol cluster. Viruses. 2020;12:706. doi: 10.3390/v12070706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070706</ArticleId><ArticleId IdType="pmc">PMC7412211</ArticleId><ArticleId IdType="pubmed">32629843</ArticleId></ArticleIdList></Reference><Reference><Citation>Valesano AL, Taniuchi M, Fitzsimmons WJ, Islam MO, Ahmed T, Zaman K, et al. The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks. Cell Host Microbe. 2021;29:32&#x2013;43. doi: 10.1016/j.chom.2020.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.10.011</ArticleId><ArticleId IdType="pmc">PMC7815045</ArticleId><ArticleId IdType="pubmed">33212020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura K, Shimizu H. The molecular evolution of type 2 vaccine-derived polioviruses in individuals with primary immunodeficiency diseases. Viruses. 2021;13:1403. doi: 10.3390/v13071407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071407</ArticleId><ArticleId IdType="pmc">PMC8310373</ArticleId><ArticleId IdType="pubmed">34372613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter RW, Prevots DR, Cochi SL. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin North Am. 2000;47:287&#x2013;308. doi: 10.1016/S0031-3955(05)70208-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-3955(05)70208-X</ArticleId><ArticleId IdType="pubmed">10761505</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkova EA, Gmyl AP, Yakovenko ML, Ivanova OE, Eremeeva TP, Kozlovskaya LI, et al. A cluster of paralytic poliomyelitis cases due to transmission of slightly diverged sabin 2 vaccine poliovirus. J Virol. 2016;90:5978&#x2013;5988. doi: 10.1128/JVI.00277-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00277-16</ArticleId><ArticleId IdType="pmc">PMC4907227</ArticleId><ArticleId IdType="pubmed">27099315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming LC, Hussain Z, Yeoh SF, Koh D, Lee KS. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication. Global Health. 2020;16:63. doi: 10.1186/s12992-020-00594-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-020-00594-z</ArticleId><ArticleId IdType="pmc">PMC7364572</ArticleId><ArticleId IdType="pubmed">32677974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Ma X, Tang H, Zhang Y, Chen N, Kaisaier W, et al. Circulation of type 2 vaccine-derived poliovirus in China in 2018&#x2013;2019. Open Forum Infect Dis. 2021;8:ofab535. doi: 10.1093/ofid/ofab535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab535</ArticleId><ArticleId IdType="pmc">PMC8677525</ArticleId><ArticleId IdType="pubmed">34926714</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkova EA, Prostova MA, Gmyl AP, Kozlovskaya LI, Eremeeva TP, Baikova OY, et al. Case of poliomyelitis caused by significantly diverged derivative of the poliovirus type 3 vaccine sabin strain circulating in the orphanage. Viruses. 2020;12:970. doi: 10.3390/v12090970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090970</ArticleId><ArticleId IdType="pmc">PMC7552002</ArticleId><ArticleId IdType="pubmed">32883046</ArticleId></ArticleIdList></Reference><Reference><Citation>Macklin G, Diop OM, Humayun A, Shahmahmoodi S, El-Sayed ZA, Triki H, et al. Update on immunodeficiency-associated vaccine-derived polioviruses&#x2014;worldwide, July 2018-December 2019. Morb Mortal Wkly Rep. 2020;69:913&#x2013;917. doi: 10.15585/mmwr.mm6928a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6928a4</ArticleId><ArticleId IdType="pmc">PMC7366852</ArticleId><ArticleId IdType="pubmed">32673297</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33:1235&#x2013;1242. doi: 10.1016/j.vaccine.2015.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.01.018</ArticleId><ArticleId IdType="pmc">PMC5529169</ArticleId><ArticleId IdType="pubmed">25600519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yan D, Zhu S, Wen N, Li L, Wang H, et al. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission. J Infect Dis. 2010;202:1780&#x2013;1788. doi: 10.1086/657410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/657410</ArticleId><ArticleId IdType="pubmed">21050127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HB, Luo HM, Li L, Fan CX, Hao LX, Ma C, et al. Vaccine-derived poliovirus surveillance in China during 2001&#x2013;2013: the potential challenge for maintaining polio free status. BMC Infect Dis. 2017;17:742. doi: 10.1186/s12879-017-2849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2849-z</ArticleId><ArticleId IdType="pmc">PMC5712118</ArticleId><ArticleId IdType="pubmed">29197328</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Zhang Y. Isolation and characterization of vaccine-derived polioviruses, relevance for the global polio eradication initiative. Methods Mol Biol. 2016;1387:213&#x2013;226. doi: 10.1007/978-1-4939-3292-4_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_10</ArticleId><ArticleId IdType="pubmed">26983736</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM. Molecular properties of poliovirus isolates: nucleotide sequence analysis, typing by PCR and real-time RT-PCR. Methods Mol Biol. 2016;1387:177&#x2013;212. doi: 10.1007/978-1-4939-3292-4_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_9</ArticleId><ArticleId IdType="pubmed">26983735</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z, Zhang Y, Liu Y, Xu A, Lin X, Yoshida H, et al. Isolation and characterization of a type 2 vaccine-derived poliovirus from environmental surveillance in China, 2012. PLoS ONE. 2013;8:e83975. doi: 10.1371/journal.pone.0083975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083975</ArticleId><ArticleId IdType="pmc">PMC3873410</ArticleId><ArticleId IdType="pubmed">24386319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Harrington C, Gerloff N, Mandelbaum M, Jeffries-Miles S, Apostol LNG, et al. Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network. PLoS ONE. 2021;16:e0255795. doi: 10.1371/journal.pone.0255795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255795</ArticleId><ArticleId IdType="pmc">PMC8345876</ArticleId><ArticleId IdType="pubmed">34358268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yan D, Zhu S, Nishimura Y, Ye X, Wang D, et al. An insight into recombination with enterovirus species C and nucleotide G-480 reversion from the viewpoint of neurovirulence of vaccine-derived polioviruses. Sci Rep. 2015;5:17291. doi: 10.1038/srep17291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17291</ArticleId><ArticleId IdType="pmc">PMC4658552</ArticleId><ArticleId IdType="pubmed">26603565</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003;77:8366&#x2013;8377. doi: 10.1128/JVI.77.15.8366-8377.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.15.8366-8377.2003</ArticleId><ArticleId IdType="pmc">PMC165252</ArticleId><ArticleId IdType="pubmed">12857906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022&#x2013;3027. doi: 10.1093/molbev/msab120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab120</ArticleId><ArticleId IdType="pmc">PMC8233496</ArticleId><ArticleId IdType="pubmed">33892491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008;137:168&#x2013;172. doi: 10.1016/j.virusres.2008.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2008.07.006</ArticleId><ArticleId IdType="pubmed">18674576</ArticleId></ArticleIdList></Reference><Reference><Citation>Savolainen-Kopra C, Samoilovich E, Kahelin H, Hiekka AK, Hovi T, Roivainen M. Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages. J Gen Virol. 2009 doi: 10.1099/vir.0.010942-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.010942-0</ArticleId><ArticleId IdType="pubmed">19403755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma DK, Nalavade UP, Varose SY, Deshpande JM. Vaccine-derived polioviruses not detected by global surveillance screening assay. Emerg Infect Dis. 2015;21:1880&#x2013;1881. doi: 10.3201/eid2110.150702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2110.150702</ArticleId><ArticleId IdType="pmc">PMC4593449</ArticleId><ArticleId IdType="pubmed">26402584</ArticleId></ArticleIdList></Reference><Reference><Citation>Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012;9:772. doi: 10.1038/nmeth.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2109</ArticleId><ArticleId IdType="pmc">PMC4594756</ArticleId><ArticleId IdType="pubmed">22847109</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312&#x2013;1313. doi: 10.1093/bioinformatics/btu033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu033</ArticleId><ArticleId IdType="pmc">PMC3998144</ArticleId><ArticleId IdType="pubmed">24451623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152&#x2013;160. doi: 10.1128/JVI.73.1.152-160.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.1.152-160.1999</ArticleId><ArticleId IdType="pmc">PMC103818</ArticleId><ArticleId IdType="pubmed">9847317</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzino BC, Jue H, Miller CM, Cheung E, Fuchs G, Fraser CS. Molecular mechanism of poliovirus Sabin vaccine strain attenuation. J Biol Chem. 2018;293:15471&#x2013;15482. doi: 10.1074/jbc.RA118.004913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004913</ArticleId><ArticleId IdType="pmc">PMC6177584</ArticleId><ArticleId IdType="pubmed">30126841</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013;87:4907&#x2013;4922. doi: 10.1128/JVI.02954-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02954-12</ArticleId><ArticleId IdType="pmc">PMC3624331</ArticleId><ArticleId IdType="pubmed">23408630</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D, Wang D, Zhang Y, Li X, Tang H, Guan J, et al. Implication of a high risk for type 2 vaccine-derived poliovirus emergence and transmission after the switch from trivalent to bivalent oral poliovirus vaccine. J Infect Dis. 2021;223:113&#x2013;118. doi: 10.1093/infdis/jiaa386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa386</ArticleId><ArticleId IdType="pubmed">32621746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer O. Polio: WHO declares type 3 poliovirus eradicated after 31 year campaign. BMJ. 2019;367:l6201. doi: 10.1136/bmj.l6201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6201</ArticleId><ArticleId IdType="pubmed">31649018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>